Comments*

 
  • Life Sciences & Biomedical Research

  • Upcoming Events by Topic

    Saturday, January 28, 2017 | 11:00 AM - 4:00 PM

    Risky Business — The Future of Biopharmaceutical Innovation

    This event gives professionals from across the biopharmaceutical space — from scientists and industry executives, through healthcare providers and insurers to investors — a visceral understanding of how biopharma innovation dynamics are evolving, mimicking decision-making under pressure in a complex and changing environment.

    Monday, February 6, 2017 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Scott Keeney (Memorial Sloan Kettering Cancer Center), Molly Przeworski (Columbia University), Agata Smogorzewska (The Rockefeller University), and Shan Zha (Columbia University Medical Center), Upasana Roy (Stony Brook University, Schärer Lab), and Simona Giunta (The Rockefeller University, Funabiki Lab)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    February 27 - 28, 2017

    Frontiers in Cancer Immunotherapy

    Keynote Speaker: James P. Allison (University of Texas MD Anderson Cancer Center)

    Discover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer from leading experts in immunotherapy.
     
    This event is sold out.

    Wednesday, March 1, 2017 | 9:00 AM - 5:00 PM

    Quantitative Approaches in Immuno-Oncology

    Keynote Speaker: Harlan Robins (Fred Hutchinson Cancer Research Center)

    This symposium will explore the emerging field of quantitative immuno-oncology, covering the breadth of scientific topics and methods needed to quantify interactions between tumors and the immune system.

    Monday, March 13, 2017 | 9:00 AM - 5:00 PM

    Targeting Tau in Alzheimer's Disease and Related Disorders

    Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Bernardino Ghetti, (Indiana University School of Medicine), Andreas Muhs (AC Immune SA), Michal Novák (AXON Neuroscience SE), Einar M. Sigurdsson (NYU School of Medicine), Henrik Zetterberg (University of Gothenburg, Sweden), and Khalid Iqbal (New York State Institute for Basic Research)

    This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.

    March 15 - 16, 2017

    The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?

    Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.

    Tuesday, March 21, 2017 | 12:00 PM - 5:00 PM

    Exosomes in the CNS

    Speakers: Tsuneya Ikezu (Boston University School of Medicine), David Issadore (University of Pennsylvania), Xandra Breakefield (Massachusetts General Hospital), Efrat Levy (NYU School of Medicine), Robert A. Rissman (University of California San Diego, School of Medicine), and Andrew West (The University of Alabama at Birmingham)

    In this symposium we will explore the contribution of extracellular vesicles to pathological processes underling neurodegenerative disorders, and the appeal of exosomes as biomarkers and targets for the development of novel therapeutics.

    Monday, April 10, 2017 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Hironori Funabiki (The Rockefeller University), Tony Huang (NYU School of Medicine), Amy MacQueen (Wesleyan University), and Jessica Tyler (Weill Cornell Medical College)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

    Gene Therapy for Rare Diseases

    Speakers: Brian Kaspar (Nationwide Children's Hospital), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida, Powell Gene Therapy Center), Maria Escolar (Children's Hospital of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and David Pearce (Sanford Research)

    Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in the field, and identify ongoing obstacles on the path to wider use of this approach.

    Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM

    Complement Pathways in Disease

    Keynote Speaker: V. Michael Holers (University of Colorado)

    The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders.